---
title: "Alamar Biosciences, Inc. (ALMR.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALMR.US.md"
symbol: "ALMR.US"
name: "Alamar Biosciences, Inc."
datetime: "2026-04-17T20:43:23.256Z"
locales:
  - [en](https://longbridge.com/en/quote/ALMR.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALMR.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALMR.US.md)
---

# Alamar Biosciences, Inc. (ALMR.US)

## Company Overview

Alamar Biosciences, Inc. operates as a proteomics company providing high-sensitivity protein biomarker analysis and precision proteomics solutions to support research and early disease detection. The company offers the NULISA proteomics platform for ultra-sensitive, multiplexed detection of protein biomarkers from small liquid biopsy specimens, and the ARGO HT system, a fully automated, high-throughput platform for biomarker profiling, validation, and clinical translation. Its services include integrated, cloud-based analytics, high-throughput sample processing, and pooled next-generation sequencing library preparation.

| Item | Detail |
|------|--------|
| Exchange | US Market |
| Website | [alamarbio.com](https://alamarbio.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ALMR.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ALMR.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ALMR.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ALMR.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**